Evidence map›Paper›PMID 21398645›Full record

ReviewEuropean heart journal2011

Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.

Juerg Schwitter, Andrew E Arai

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in European heart journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03152825 (Stress Perfusion Cardiac Magnetic Resonance for Ischaemia and Viability Detection in Patients With Coronary Chronic Total Occlusions), which is not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03152825 unknown statusnot on this mapstarted 2017, after this paper: background citation

Stress Perfusion Cardiac Magnetic Resonance for Ischaemia and Viability Detection in Patients With Coronary Chronic Total Occlusions

Typeobservational_patient_registrySponsorOspedale San DonatoRan2017 to 2023Enrolled400ConditionsCoronary Chronic Total OcclusionsArmsPCI
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2020
    Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. [Ischemic heart disease : More than just chronic CAD].Radiologie (Heidelberg, Germany) · 2022
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Role of cardiovascular magnetic resonance in acute and chronic ischemic heart disease.The international journal of cardiovascular imaging · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Juerg SchwitterDepartment of Cardiology, University Hospital Lausanne-CHUV, Rue du Bugnon 46, Lausanne, Switzerland. jurg.schwitter@chuv.ch
Andrew E Arai
Hôpital Orthopédique de la Suisse Romande · CHNational Heart Lung and Blood Institute · US

Funding

Technical Development of Diagnostic Cardiovascular MRIZIAHL004607 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ARAI, ANDREW · 2009 to 2020
$25.3M
Quantification of Myocardial PerfusionZIAHL006137 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ARAI, ANDREW · 2011 to 2020
$9.4M
Clinical Advanced Cardiovascular ImagingZIDHL006140 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ARAI, ANDREW · 2011 to 2020
$8.2M
MRI Evaluation Of Acute Cardiovascular DiseaseZ01HL004607 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ARAI, ANDREW E · 1999 to 2008
$8.0M
Area at Risk, Myocardial Infarction, and Myocardial SalvageZIAHL006136 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ARAI, ANDREW · 2011 to 2020
$7.3M
Intramural NIH HHS Z01 HL004607Intramural NIH HHS ZIA HL004607Intramural NIH HHS ZID HL006140
6 · The paper itself

Abstract

Over the past years, cardiovascular magnetic resonance (CMR) has proven its efficacy in large clinical trials, and consequently, the assessment of function, viability, and ischaemia by CMR is now an integrated part of the diagnostic armamentarium in cardiology. By combining these CMR applications, coronary artery disease (CAD) can be detected in its early stages and this allows for interventions with the goal to reduce complications of CAD such as infarcts and subsequently chronic heart failure (CHF). As the CMR examinations are robust and reproducible and do not expose patients to radiation, they are ideally suited for repetitive studies without harm to the patients. Since CAD is a chronic disease, the option to monitor CAD regularly by CMR over many decades is highly valuable. Cardiovascular magnetic resonance also progressed recently in the setting of acute coronary syndromes. In this situation, CMR allows for important differential diagnoses. Cardiovascular magnetic resonance also delineates precisely the different tissue components in acute myocardial infarction such as necrosis, microvascular obstruction (MVO), haemorrhage, and oedema, i.e. area at risk. With these features, CMR might also become the preferred tool to investigate novel treatment strategies in clinical research. Finally, in CHF patients, the versatility of CMR to assess function, flow, perfusion, and viability and to characterize tissue is helpful to narrow the differential diagnosis and to monitor treatment.

Indexed as

Cardiotonic AgentsChronic DiseaseContrast MediaCoronary Artery DiseaseDeath, Sudden, CardiacDiagnosis, DifferentialDobutamineFeasibility StudiesHeart FailureHumansMagnetic Resonance AngiographyMyocardial InfarctionMyocardial IschemiaPatient SafetyPrognosisCardiotonic AgentsContrast MediaDobutamine

Identifiers

PMID21398645
PMCPMC3069387
OpenAlexW2109009981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.